Arvinas

layoffs
Biotech

Arvinas lays off 33% of staff, axes Pfizer-partnered trials

Pfizer and Arvinas have axed two phase 3 trials from their estrogen receptor degrader R&D plan in the wake of mixed data.
Nick Paul Taylor May 1, 2025 8:50am
positive negative up down good bad mixed

Pfizer, Arvinas' PROTAC posts mixed results in first ph. 3 test

Mar 11, 2025 10:06am
parachute south africa cape town

Marea, Ashibio, Arvinas & more—Chutes & Ladders

Jun 21, 2024 8:30am
parachute mountains sunset clouds

Xaira, Anthos, CureVac & more—Chutes & Ladders

Apr 26, 2024 8:30am
Three blocks displaying from left to right a person a handshake and another person

Novartis pays $150M for Arvinas' prostate tumor protein degrader

Apr 11, 2024 8:04am
parachute chutes

Bayer undergoes leadership shake-up—Chutes & Ladders

Mar 22, 2024 9:30am